Retinal imaging in Alzheimer's and neurodegenerative diseases.


Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
01 2021
Historique:
received: 26 05 2020
revised: 26 07 2020
accepted: 27 07 2020
pubmed: 23 10 2020
medline: 26 10 2021
entrez: 22 10 2020
Statut: ppublish

Résumé

In the last 20 years, research focused on developing retinal imaging as a source of potential biomarkers for Alzheimer's disease and other neurodegenerative diseases, has increased significantly. The Alzheimer's Association and the Alzheimer's & Dementia: Diagnosis, Assessment, Disease Monitoring editorial team (companion journal to Alzheimer's & Dementia) convened an interdisciplinary discussion in 2019 to identify a path to expedite the development of retinal biomarkers capable of identifying biological changes associated with AD, and for tracking progression of disease severity over time. As different retinal imaging modalities provide different types of structural and/or functional information, the discussion reflected on these modalities and their respective strengths and weaknesses. Discussion further focused on the importance of defining the context of use to help guide the development of retinal biomarkers. Moving from research to context of use, and ultimately to clinical evaluation, this article outlines ongoing retinal imaging research today in Alzheimer's and other brain diseases, including a discussion of future directions for this area of study.

Identifiants

pubmed: 33090722
doi: 10.1002/alz.12179
pmc: PMC8062064
mid: NIHMS1691189
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

103-111

Subventions

Organisme : NIA NIH HHS
ID : P01 AG012435
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG005142
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG055865
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG056478
Pays : United States

Informations de copyright

© 2020 Alzheimer's Association. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

Références

Alzheimers Dement. 2018 Apr;14(4):535-562
pubmed: 29653606
Acta Neuropathol. 2016 May;131(5):725-36
pubmed: 26975356
JAMA Ophthalmol. 2018 Nov 1;136(11):1242-1248
pubmed: 30352114
Invest Ophthalmol Vis Sci. 2017 Apr 1;58(4):2160-2165
pubmed: 28395300
PLoS One. 2018 Dec 28;13(12):e0209194
pubmed: 30592718
Alzheimers Dement (Amst). 2018 Feb 07;10:196-209
pubmed: 29780864
J Alzheimers Dis. 2020;73(3):1201-1209
pubmed: 31884473
Front Neurol. 2018 Dec 07;9:1047
pubmed: 30581410
Mol Psychiatry. 2017 Mar;22(3):353-363
pubmed: 28093567
Acta Neuropathol Commun. 2018 Dec 28;6(1):147
pubmed: 30593285
Alzheimers Dement (Amst). 2015 May 16;1(2):229-235
pubmed: 26634224
Int J Retina Vitreous. 2016 Apr 8;2:12
pubmed: 27847630
Ophthalmology. 2019 Apr;126(4):497-510
pubmed: 30114417
JAMA Neurol. 2015 Mar;72(3):316-24
pubmed: 25580592
Br J Ophthalmol. 2018 Feb;102(2):233-237
pubmed: 28600299
J Clin Med. 2019 Jul 09;8(7):
pubmed: 31323964
Neuroreport. 2011 Aug 24;22(12):623-7
pubmed: 21734608
Neurobiol Aging. 2006 Jul;27(7):983-93
pubmed: 15979212
Neurol Clin Pract. 2015 Oct;5(5):460-469
pubmed: 29443181
Front Neurol. 2019 Apr 12;10:360
pubmed: 31031692
Alzheimers Dement. 2018 Aug;14(8):981-988
pubmed: 29802030
Sci Transl Med. 2011 Nov 30;3(111):111cm33
pubmed: 22133718
Sci Transl Med. 2014 Mar 19;6(228):228fs13
pubmed: 24648338
Invest Ophthalmol Vis Sci. 2014 Jan 29;55(1):523-34
pubmed: 24398104
Ann Neurol. 2016 Jan;79(1):90-109
pubmed: 26505992
Acta Ophthalmol. 2015 Jun;93(4):e241-7
pubmed: 25482990
Acta Neuropathol Commun. 2018 Aug 9;6(1):75
pubmed: 30092839
Alzheimers Dement. 2017 Jan;13(1):45-58
pubmed: 27870940
Am J Physiol Heart Circ Physiol. 2017 Feb 1;312(2):H201-H212
pubmed: 27923786
JAMA Neurol. 2018 Oct 1;75(10):1256-1263
pubmed: 29946702
JAMA Neurol. 2018 Oct 1;75(10):1198-1205
pubmed: 29946685
Neurology. 2018 Oct 2;91(14):e1295-e1306
pubmed: 30217935
Nat Rev Neurol. 2018 Nov;14(11):639-652
pubmed: 30297701
PLoS One. 2019 Dec 10;14(12):e0226197
pubmed: 31821378
Alzheimers Dement. 2016 Mar;12(3):292-323
pubmed: 27012484
Alzheimers Dement (Amst). 2018 Nov 12;11:19-27
pubmed: 30581972
Nat Commun. 2019 Sep 17;10(1):4227
pubmed: 31530809
Biomark Med. 2010 Apr;4(2):241-63
pubmed: 20406068
Alzheimers Dement (Amst). 2017 Jan 25;6:162-170
pubmed: 28275698
Cell Death Dis. 2018 Jun 7;9(6):685
pubmed: 29880901
Front Behav Neurosci. 2015 Sep 14;9:239
pubmed: 26441570
JCI Insight. 2017 Aug 17;2(16):
pubmed: 28814675
Nat Med. 2001 Apr;7(4):502-7
pubmed: 11283681
Sci Rep. 2019 Jan 11;9(1):63
pubmed: 30635610
Alzheimers Dement (Amst). 2016 Oct 01;4:169-178
pubmed: 27830174
ACS Chem Neurosci. 2019 Nov 20;10(11):4492-4501
pubmed: 31603648
Nature. 2018 Feb 8;554(7691):249-254
pubmed: 29420472
J Alzheimers Dis. 2018;62(3):1181-1198
pubmed: 29562526
Sci Rep. 2020 Jan 31;10(1):1580
pubmed: 32005868
Alzheimers Dement. 2018 Feb;14(2):121-129
pubmed: 29233480
Alzheimers Dement. 2014 Jan;10(1):109-14
pubmed: 24365657
Invest Ophthalmol Vis Sci. 2014 Sep 16;55(10):6505-13
pubmed: 25228542
Acta Neuropathol. 2020 May;139(5):813-836
pubmed: 32043162
Front Aging Neurosci. 2018 Jun 22;10:188
pubmed: 29988470
PLoS One. 2020 May 29;15(5):e0232785
pubmed: 32469871
Am J Ophthalmol. 2017 Sep;181:106-113
pubmed: 28669780
PLoS One. 2012;7(12):e53547
pubmed: 23300938
J Neuroophthalmol. 2018 Sep;38(3):292-298
pubmed: 29040211
Brain. 2017 Jun 1;140(6):1757-1767
pubmed: 28449038
Alzheimers Dement. 2020 Jan;16(1):229-243
pubmed: 31914225
Eye (Lond). 2019 Aug;33(8):1271-1279
pubmed: 30923356
Acta Neuropathol Commun. 2016 Aug 18;4(1):86
pubmed: 27535749
Neuroimage. 2011 Jan;54 Suppl 1:S204-17
pubmed: 20550967
Alzheimers Dement. 2011 May;7(3):280-92
pubmed: 21514248
Front Neurosci. 2019 Sep 04;13:925
pubmed: 31551688
Acta Ophthalmol. 2017 Dec;95(8):768-777
pubmed: 29220126
Expert Rev Mol Diagn. 2020 Jul;20(7):737-748
pubmed: 32310684
Front Physiol. 2018 Dec 06;9:1721
pubmed: 30574092

Auteurs

Peter J Snyder (PJ)

Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island.

Jessica Alber (J)

Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island.

Clemens Alt (C)

Wellman Center for Photomedicine and Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

Lisa J Bain (LJ)

Independent Science Writer, Elverson, Pennsylvania.

Brett E Bouma (BE)

Harvard Medical School, Massachusetts General Hospital and Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Massachusetts.

Femke H Bouwman (FH)

Neurologist, Alzheimer Center Amsterdam UMC, Amsterdam, The Netherlands.

Delia Cabrera DeBuc (DC)

Bascom Palmer Eye Institute, University of Miami, Miami, Florida.

Melanie C W Campbell (MCW)

Physics and Astronomy, Optometry and Vision Science and Systems Design Engineering, University of Waterloo, Waterloo, Ontario, Canada.

Maria C Carrillo (MC)

Medical & Scientific Relations, Alzheimer's Association, Chicago, Illinois.

Emily Y Chew (EY)

Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.

M Francesca Cordeiro (MF)

Imperial College London, UCL Institute of Ophthalmology, ICORG Western Eye Hospital, London, UK.

Michael R Dueñas (MR)

Chief Public Health Officer (Ret.), American Optometric Association, Washington, D.C.

Brian M Fernández (BM)

Clinical Affairs, Heidelberg Engineering, Franklin, Massachusetts.

Maya Koronyo-Hamaoui (M)

Department of Neurosurgery, Maxine Dunitz Neurosurgical Research Institute and Department of Biomedical Sciences, Division of Applied Cell Biology and Physiology, Cedars-Sinai Medical Center, Los Angeles, California.

Chiara La Morgia (C)

IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna, Italy.
Dipartimento di Scienze Biomediche e Neuromotorie, University of Bologna, Italy.

Roxana O' Carare (RO)

University of Southampton, Southampton, UK.

Srinivas R Sadda (SR)

Doheny Eye Institute, Los Angeles, California.
Department of Ophthalmology, UCLA, Los Angeles, California.

Peter van Wijngaarden (P)

Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia.
Ophthalmology, Department of Surgery, University of Melbourne, Parkville, Australia.

Heather M Snyder (HM)

Medical & Scientific Relations, Alzheimer's Association, Chicago, Illinois.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH